FDA Approves Rare Pediatric Disease Designation for IMX-110 for Rhabdomyosarcoma

Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with rhabdomyosarcoma.

Read more: https://www.pharmacytimes.com/view/fda-approves-rare-pediatric-disease-designation-for-imx-110-for-rhabdomyosarcoma